Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
Journal of Chemical Information and Modeling|February 2, 2023
Chemistry42: An AI-Driven Platform for Molecular Design and OptimizationYan A Ivanenkov, Daniil Polykovskiy, Dmitry Bezrukov, et al.Trends in Pharmacological Sciences|May 22, 2024
TNIK's emerging role in cancer, metabolism, and age-related diseasesCollin Y Ewald, Fadi E Pulous, Sarah Wing Yan Lok, et al.Aging|February 27, 2025
Variability in radiotherapy outcomes across cancer types: a comparative study of glioblastoma multiforme and low-grade gliomasAlexander Veviorskiy, Garik V Mkrtchyan, Andreyan N Osipov, et al.ACS Medicinal Chemistry Letters|July 19, 2023
The Hitchhiker's Guide to Deep Learning Driven Generative ChemistryYan Ivanenkov, Bogdan Zagribelnyy, Alex Malyshev, et al.Bioorganic & Medicinal Chemistry|February 5, 2026
Conformational restriction of hinge carboxamide leading to potent lactam-based PKMYT1 inhibitorsYazhou Wang, Xiaomin Wang, Chao Wang, et al.Bioorganic & Medicinal Chemistry|March 17, 2024
Discovery of 3-hydroxymethyl-azetidine derivatives as potent polymerase theta inhibitorsYazhou Wang, Chao Wang, Jinxin Liu, et al.Chemmedchem|March 26, 2026
An Internal Sulfur-Lone Pair Interaction Enabled the Discovery of Potent and Sub-Family Selective PKMYT1 InhibitorsYazhou Wang, Chao Wang, Xiaomin Wang, et al.Aging and Disease|June 15, 2026
Integrating AI and Causal Genetics to Prioritize Therapeutic Targets for Aging and Age-Related DiseasesGeoffrey H D Leung, Jianjiu Chen, I Aylin Ergun, et al.Journal of Medicinal Chemistry|November 25, 2024
Discovery of Pyridine-2-Carboxamides Derivatives as Potent and Selective HPK1 Inhibitors for the Treatment of CancerJingjing Peng, Xiaoyu Ding, Celia Xiaojing Chen, et al.European Journal of Medicinal Chemistry|September 20, 2024
Discovery of 1(2H)-phthalazinone and 1(2H)-isoquinolinone derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitorsJingjing Peng, Xiaoyu Ding, Pei-Yu Shih, et al.Pageof 7